Document outlines potential regulatory path for federal cannabis legalization and mentions DEA/FDA actions under Attorney General Sessions

The passage provides a general overview of how the DEA and FDA could enable federal cannabis legalization without a change in law and references a 2016 DEA policy and the current DOJ leadership. It hi DEA can register manufacturers to produce medical cannabis under the CSA. FDA can approve cannabis‑derived drugs under the FD&C Act. A 2016 DEA policy aimed to increase the number of registered canna